Lazard Asset Management »

Jasper Therapeutics shares owned by Lazard Asset Management

Quarter-by-quarter ownership of Jasper Therapeutics shares owned by Lazard Asset Management from 13F filings

Historical chart of Lazard Asset Management investment in Jasper Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Jasper Therapeutics held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jasper Therapeutics by Lazard Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $0 12k 0.00
2023-09-30 $0 11k 0.00

More positions owned by Lazard Asset Management

Microsoft Corp Common Stock (MSFT)
Alphabet Inc A Common Stock (GOOGL)
Amazon.com Common Stock (AMZN)
Norfolk Souther Common Stock (NSC)
Visa Common Stock (V)
Accenture Common Stock (ACN)
Intercontinen Common Stock (ICE)
Unitedhealth Gr Common Stock (UNH)
Aon Plc/ireland Common Stock (AON)
Bank Of America Common Stock (BAC)
Thermo Fisher Common Stock (TMO)
Analog Devices Common Stock (ADI)
Mcdonalds Corp Common Stock (MCD)
John & John Common Stock (JNJ)
Amer Express Common Stock (AXP)

View all positions for Lazard Asset Management

Top funds holding Jasper Therapeutics

Soleus Capital Management
Carlyle
Qiming U.S. Ventures Management
Octagon Capital Advisors
Vanguard Group
Opaleye Management
Kingdon Capital Management
Bank of America Corporation
Nantahala Capital Management
Landscape Capital Management
Sphera Funds Management
Mariner Wealth Advisors
Bank Of Montreal
Monaco Asset Management SAM
Citadel Advisors

View all funds holding Jasper Therapeutics